Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Dr Natalie Thomas is an Early Career Researcher (ECR) within the Women’s Mental Health Division at Monash University who works within the evolving fields of neuroendocrine research and related biomarker studies, using her interdisciplinary skills in laboratory sciences and clinical research. Dr Thomas was recruited to Monash University upon completion of her PhD studies in 2016 to work within the Department of Psychiatry, Central Clinical School (CCS). Dr Thomas provides unique molecular biology and biochemistry experience to the division, and now leads the molecular biology and biomarker research arms. Her work involves close collaborations with psychiatry, neurology, endocrinology, psychology, and immunology and aims to characterise the neurobiological underpinnings of patient and healthy human populations and to develop blood and saliva-based biomarkers for the field of neuroscience. To this end, Dr Thomas led the establishment of the Monash Alfred Psychiatry research centre (MAPrc) Psychiatric BioRepositry in 2017 that houses comprehensive demographic, behavioural, mood, and cognitive data alongside plasma, serum, DNA/RNA, and saliva samples of both the healthy population and psychiatric patients.

Education/Academic qualification

Molecular Psychiatry , Doctor of Philosophy (PhD), University of Melbourne

Molecular Biology and Biochemistry , Bachelor Science (Honours), University of Melbourne

Research area keywords

  • Biomarkers
  • Psychoneuroendocrinology
  • Neurobiology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

Borderline personality disorder, trauma, and the hypothalamus-pituitary-adrenal axis

Thomas, N., Gurvich, C. & Kulkarni, J., 1 Jan 2019, In : Neuropsychiatric Disease and Treatment. 15, p. 2601-2612 12 p.

Research output: Contribution to journalReview ArticleOtherpeer-review

Open Access

Dissecting the syndrome of schizophrenia: Associations between symptomatology and hormone levels in women with schizophrenia

Thomas, N., Gurvich, C., Hudaib, A. R., Gavrilidis, E. & Kulkarni, J., 1 Oct 2019, In : Psychiatry Research. 280, 7 p., 112510.

Research output: Contribution to journalArticleResearchpeer-review

Improvement in depression with oestrogen treatment in women with schizophrenia

Lascurain, M. B., Camuñas-Palacín, A., Thomas, N., Breadon, C., Gavrilidis, E., Hudaib, A. R., Gurvich, C. & Kulkarni, J., 21 Mar 2019, (Accepted/In press) In : Archives of Women's Mental Health. 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Raloxifene as a treatment for cognition in women with schizophrenia: the influence of menopause status

Gurvich, C., Hudaib, A., Gavrilidis, E., Worsley, R., Thomas, N. & Kulkarni, J., 1 Feb 2019, In : Psychoneuroendocrinology. 100, p. 113-119 7 p.

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)

Sex Differences in Aging and Associated Biomarkers

Thomas, N., Gurvich, C. & Kulkarni, J., 2019, Reviews on Biomarker Studies in Aging and Anti-Aging Research. Guest, P. C. (ed.). Switzerland AG: Springer, p. 57-76 20 p. (Advances in Experimental Medicine and Biology; vol. 1178).

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

1 Citation (Scopus)